Waverley Pharma Inc. WAVE.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -101.20K | -119.00K | -141.50K | -172.80K | -20.10K |
| Total Depreciation and Amortization | 14.50K | 14.70K | 14.90K | 14.90K | 14.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.90K | 21.20K | 21.20K | 53.20K | -12.80K |
| Change in Net Operating Assets | 8.00K | 36.30K | -68.40K | 3.90K | -31.30K |
| Cash from Operations | -57.80K | -46.80K | -173.80K | -100.80K | -49.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -189.70K | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 189.70K | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 65.90K | 96.50K | 229.60K | 67.50K | 80.10K |
| Total Debt Repaid | -8.20K | -8.40K | -7.80K | -8.20K | -8.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 40.60K | 63.30K | 159.00K | 43.00K | 52.00K |
| Foreign Exchange rate Adjustments | 500.00 | 500.00 | -1.50K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.60K | 17.00K | -16.30K | -57.80K | 2.60K |